Wright, D.

Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia

Rolnik, D. L., Wright, D., Poon, L. C., O’Gorman, N., Syngelaki, A., de Paco Matallana, C., Akolekar, R., Cicero, S., Janga, D., Singh, M., et al. (2017) · New England Journal of Medicine

Pregnancy and preeclampsia studiesNeurological Complications and Syndromes

Cited by 2,287

Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial

Zajicek, J., Fox, P., Sanders, H., Wright, D., Vickery, J., Nunn, A., & Thompson, A. (2003) · The Lancet

Cannabis and Cannabinoid ResearchMultiple Sclerosis Research Studies

Cited by 827

Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation

O’Gorman, N., Wright, D., Syngelaki, A., Akolekar, R., Wright, A., Poon, L. C., & Nicolaides, K. H. (2016) · American Journal of Obstetrics and Gynecology

Pregnancy and preeclampsia studiesNeurological Complications and Syndromes

Cited by 629

Screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks’ gestation

Tan, M. Y., Syngelaki, A., Poon, L. C., Rolnik, D. L., O'Gorman, N., Delgado, J. L., Akolekar, R., Konstantinidou, L., Tsavdaridou, M., Galeva, S., et al. (2018) · Ultrasound in Obstetrics & Gynecology

Pregnancy and preeclampsia studiesPrenatal Screening and Diagnostics

Cited by 438

Ductus venosus Doppler in screening for trisomies 21, 18 and 13 and Turner syndrome at 11–13 weeks of gestation

Maiz, N., Valencia, C., Kagan, K. O., Wright, D., & Nicolaides, K. H. (2009) · Ultrasound in Obstetrics & Gynecology

Prenatal Screening and DiagnosticsFetal and Pediatric Neurological Disorders

Cited by 206

Prediction of small-for-gestation neonates from biophysical and biochemical markers at 11-13 weeks

Karagiannis, G., Akolekar, R., Sarquis, R., Wright, D., & Nicolaides, K. H. (2011) · Fetal Diagnosis and Therapy

Pregnancy and preeclampsia studiesPrenatal Screening and Diagnostics

Cited by 195

Tricuspid regurgitation in screening for trisomies 21, 18 and 13 and Turner syndrome at 11 + 0 to 13 + 6 weeks of gestation

Kagan, K. O., Valencia, C., Livanos, P., Wright, D., & Nicolaides, K. H. (2009) · Ultrasound in Obstetrics & Gynecology

Prenatal Screening and DiagnosticsDown syndrome and intellectual disability research

Cited by 175

Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down's syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units

Chitty, L. S., Wright, D., Hill, M., Verhoef, T. I., Daley, R., Lewis, C., Mason, S., McKay, F., Jenkins, L., Howarth, A., et al. (2016) · BMJ

Prenatal Screening and DiagnosticsDown syndrome and intellectual disability research

Cited by 149

Prospective validation of first-trimester combined screening for trisomy 21

Kagan, K. O., Etchegaray, A., Zhou, Y., Wright, D., & Nicolaides, K. H. (2009) · Ultrasound in Obstetrics & Gynecology

Prenatal Screening and DiagnosticsDown syndrome and intellectual disability research

Cited by 132

Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 30-34 weeks’ gestation

Tsiakkas, A., Saiid, Y., Wright, A., Wright, D., & Nicolaides, K. H. (2016) · American Journal of Obstetrics and Gynecology

Pregnancy and preeclampsia studiesNeurological Complications and Syndromes

Cited by 119

Competing risks model in screening for preeclampsia by serum placental growth factor and soluble fms-like tyrosine kinase-1 at 30-33 weeks’ gestation

Lai, J., Garcia-Tizon Larroca, S., Peeva, G., Poon, L. C., Wright, D., & Nicolaides, K. H. (2014) · Fetal Diagnosis and Therapy

Pregnancy and preeclampsia studiesNeurological Complications and Syndromes

Cited by 63

Impact of new definitions of pre‐eclampsia on incidence and performance of first‐trimester screening

Khan, N., Andrade, W., De Castro, H., Wright, A., Wright, D., & Nicolaides, K. H. (2020) · Ultrasound in Obstetrics & Gynecology

Pregnancy and preeclampsia studiesNeurological Complications and Syndromes

Cited by 59

Competing‐risks model for prediction of small‐for‐gestational‐age neonate from maternal characteristics, serum pregnancy‐associated plasma protein‐A and placental growth factor at 11–13 weeks' gestation

Papastefanou, I., Wright, D., Lolos, M., Anampousi, K., Mamalis, M., & Nicolaides, K. H. (2021) · Ultrasound in Obstetrics & Gynecology

Pregnancy and preeclampsia studiesPrenatal Screening and Diagnostics

Cited by 40

Contingent screening for preterm pre-eclampsia

Wright, D., Gallo, D. M., Gil Pugliese, S., Casanova, C., & Nicolaides, K. H. (2016) · Ultrasound in Obstetrics & Gynecology

Pregnancy and preeclampsia studiesNeurological Complications and Syndromes

Cited by 40

Competing‐risks model for prediction of small‐for‐gestational‐age neonate from estimated fetal weight at 19–24 weeks' gestation

Papastefanou, I., Nowacka, U., Syngelaki, A., Dragoi, V., Karamanis, G., Wright, D., & Nicolaides, K. H. (2021) · Ultrasound in Obstetrics & Gynecology

Pregnancy and preeclampsia studiesPrenatal Screening and Diagnostics

Cited by 27

Economic modelling of antenatal screening and ultrasound scanning programmes for identification of fetal abnormalities

Ritchie, K., Bradbury, I., Slattery, J., Wright, D., Iqbal, K., & Penney, G. (2005) · BJOG: An International Journal of Obstetrics & Gynaecology

Prenatal Screening and DiagnosticsCongenital Anomalies and Fetal Surgery

Cited by 26